Lilly said in a statement that patients could buy the Zepbound vials for $499 per month on its LillyDirect website, roughly 23% cheaper than the $650 it charges for its injector pen to insured ...

Lily Phillips announced on Instagram that she's expecting her first baby on Wednesday, Feb. 19 Skyler Caruso is a Writer and Reporter of PEOPLE Digital Entertainment. She joined PEOPLE in 2021 ...

"The secret is out," Lily wrote in a Feb. 18 Instagram post alongside a photo of her cradling a baby bump. "Baby phillips 2025." And she shared more than just a pic as part of her announcement.

That negative investor reaction was directed at companies involved in the white-hot weight loss drug segment of the market (Eli Lilly is the pharmaceutical giant behind a popular one, Zepbound).

OnlyFans influencer Lily Phillips is often candid about her profession as a sex worker — and she’s had a lot to say, especially after sleeping with 101 men in one day. Phillips made headlines ...

Eli Lilly’s rising fortunes tied to its weight loss and diabetes drugs led to a nine-figure payday for its top executive — and covered an exclusive trip for leaders to attend last summer’s ...

Lily Phillips has dropped yet another eyebrow-raising confession. The OnlyFans model, who recently announced her pregnancy, revealed she found a condom inside her last year after accomplishing ...

Lily Allen/Instagram Allen — who recently split from husband David Harbour — acknowledged that it was an unfavorable quality of hers. “It’s incredibly like, red flag, codependent behavior ...

March 12 (Reuters) - U.S. drugmakers Johnson & Johnson (JNJ.N), opens new tab and Eli Lilly (LLY.N), opens new tab increased spending on security for their top executives in 2024, citing increased ...

OnlyFans creator Lily Phillips is pregnant with her first baby. “The secret is out ,” Phillips, 23, wrote via Instagram on Tuesday, February 18. “Baby Phillips 2025.” Alongside her ...

Eli Lilly said Tuesday that it will offer more doses of its obesity drug Zepbound in vials and lower the prices of the doses it already sells, as the pharma giant seeks to draw patients away from ...